SUMMARY An additional disorder in the spectrum of thyroid related muscle disease is presented. Hypothyroid and hyperthyroid disease are both associated with a variety of muscle abnormalities, from myalgias to myopathy. Polymyositis, however, has never been reported immediately after treatment for active hyperthyroidism. A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil (100 mg orally, three times a day). Electromyography, muscle biopsy, and the course of the patient's illness were consistent with polymyositis. Whether this represents a cause-effect association or a chance occurrence is unknown. Physician awareness of the occurrence of a variety of muscle disorders including polymyositis in thyroid disease is emphasised. A brief discussion of thyroid myopathy, thionamide drug reactions, and polymyositis is included.
Polymyositis after propylthiouracil treatment for hypertliyroidism 341 patient, however, began to experience weakness, and within one week was unable to comb her hair and arise from a seated position. CPK determination was 10 380 IU/I. Prednisone was increased to 40 mg daily, and the patient was transferred to Duke University Medical Center for further evaluation and treatment.
On arrival she complained only of weakness. Physical examination showed a thin, white woman with irregular pulse of 86 beats a minute, temperature of 36 8XC, and a mildly enlarged, smooth, nontender thyroid gland. Muscles were non-tender and strength testing showed 6 Clinically, most patients with hyperthyroidism will have some degree of proximal myopathy with the more severe and longstanding disease also involving distal and even bulbar musculature.5 6 The electromyography (EMG) of thyrotoxic myopathy, though non-specific, generally shows a decrease in fibrillation and fasiculations secondary to a reversible decrease in functioning muscle fibres.5 6 This patient had abundant fibrillations with an increase in potentials.
The muscle biopsy findings in thyrotoxic myopathy are also non-specific and include marked muscle fibre degeneration and atrophy, with connective tissue proliferation and fatty infiltration between fibres.5 6 These last two features were distinctly absent from this patient. The usual muscle enzyme pattern in thyrotoxic myopathy was also absent in this patient. Typically in hyperthyroidism the CPK is normal or decreased. Our patient had dramatically increased CPKs, thus making thyrotoxic myopathy unlikely. Only in the hypothyroid state may the CPK be raised. 6 1 In the latter state some authors have advocated the use of CPK as an indicator of response to thyroid replacement treatment. 13 One report describes hypothyroidism mimicking polymyositis.8 Our patient was consistently euthyroid after propylthiouracil treatment when she was most symptomatic from her myopathy and her CPK increases were the greatest.
Propylthiouracil and methimazole are two agents commonly used to treat hyperthyroidism and in general are relatively safe compounds. Several toxic reactions, however, have been reported.'-'7 Skin eruptions are the most common reaction followed by rheumatic complaints. The latter include myalgias, arthralgias, and arthritis. This constellation of symptoms accompanied by fever and rash has been collectively referred to as the 'antithyroid arthritis syndrome' or 'lupus-like syndrome' or 'collagen-like syndrome' associated with thyroid treatment. IWI2 16
In a discussion of the antithyroid arthritis syndrome Shabtai et al review 500 patients treated with either propylthiouracil or methimazole for hyperthyroidism. " This patient presented with severe proximal muscle weakness, raised CPKs, and an EMG and muscle biopsy suggestive of polymyositis. Although the complete EMG picture of polymyositis generally shows increased insertional activity, the two week course of prednisone before EMG study may have obscured this finding. Also, the paucity of inflammatory cells on the muscle biopsy may likewise be explained.
Idiopathic polymyositis constitutes the largest group of the dermatomyositis-polymyositis complex described by Bohan and Peter. 9 Typically, pure polymyositis affects more women than men in a ratio of about 2:1 and the mean age of presentation is 50. 21 
